Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal
Bernstein analysts reaffirmed their Market Perform rating and $30 price target for Pfizer Inc.
Pfizer Inc (PFE)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
BMO Capital Maintains Buy Rating on Pfizer (PFE) Stock
On May 20, BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer Inc. (NYSE:PFE) and kept the price target the same at $30.
Pfizer Inc. (PFE) Inks $6 Billion Cancer Drug Licensing Agreement with China’s 3SBio
On May 19, Pfizer Inc. (NYSE:PFE) announced it had entered into a licensing agreement valued at approximately $6 billion with Chinese biopharmaceutical firm 3SBio Inc.
13 Best Cheap Stocks to Invest in for Beginners
The last time the S&P erased a 15% decline in under six weeks was 1982, which tells a lot about the current market dynamics we are currently in.
13 Stocks on Jim Cramer’s Radar Recently
On Monday's episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor of staying invested, even in times of uncertainty.
13 Best High Volume Stocks to Buy Now
On May 9, BMO private wealth chief market strategist Carol Schleif joined CNBC's 'Squawk Box' to discuss the latest market trends and the state of the economy.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
15 Best High-Yield Dividend Stocks for 2025 and Beyond
Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies.
13 Stock Predictions That Jim Cramer Got Completely Wrong
During a recent episode of Mad Money, which aired on Monday, the 5th of May, Jim Cramer gave some personal anecdotes from his experience as an investor.
Jim Cramer Reveals Trump's Potential Secret Weapon In China Trade Talks & Discusses These 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the impacts that tariffs have had on businesses.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
